Aerocrine Launches a New Fully Portable Hand-Held Device to Measure Airway Inflammation in Asthma
9/11/2013 9:34:02 AM
SOLNA, Sweden – 11 September, 2013 - Aerocrine AB (OMX Nordic Exchange: AERO) is
pleased to announce the launch of NIOX VERO®, a new, fully portable hand-held
point-of-care device for the measurement of airway inflammation, such as asthma.
Aerocrine introduces the new device in conjunction with the European Respiratory
Society (ERS) annual meeting in Barcelona, September 7-11, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by